APA (7th ed.) Citation

Nora D. Mineva, Stefania Pianetti, Sonia G. Das, Srimathi Srinivasan, Nicolas M. Billiald, & Gail E. Sonenshein. (2024). A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Nora D. Mineva, Stefania Pianetti, Sonia G. Das, Srimathi Srinivasan, Nicolas M. Billiald, and Gail E. Sonenshein. A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer. MDPI AG, 2024.

MLA (9th ed.) Citation

Nora D. Mineva, et al. A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer. MDPI AG, 2024.